Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)
China flag China · Delayed Price · Currency is CNY
12.39
-0.24 (-1.90%)
Sep 6, 2024, 3:00 PM CST

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-408.95-189.451,0911,059806.12604.96
Upgrade
Depreciation & Amortization
164.94154.06139.5393.2284.5544.99
Upgrade
Other Amortization
0.190.190.190.20.230.2
Upgrade
Loss (Gain) From Sale of Assets
0.020.040.111.030.22-0.13
Upgrade
Asset Writedown & Restructuring Costs
1,2511,24410.227.2352-2.97
Upgrade
Loss (Gain) From Sale of Investments
82.9685.58-24.1-24.57-10.55-10.69
Upgrade
Provision & Write-off of Bad Debts
-3.32-3.32-0.423.22--
Upgrade
Other Operating Activities
110.12-1.96-99.4387.4755.6719.69
Upgrade
Change in Accounts Receivable
-1.54163.36-1,456-148.2-345.27-202.11
Upgrade
Change in Inventory
676.4213.28-731.57-444.05-1,223-1,230
Upgrade
Change in Accounts Payable
-27.03224.661,71046.8211.23-61.64
Upgrade
Change in Other Net Operating Assets
-56.7-21.25-15.113.4511.515.1
Upgrade
Operating Cash Flow
1,5951,619595.45683.63-565.85-841.38
Upgrade
Operating Cash Flow Growth
119.37%171.93%-12.90%---
Upgrade
Capital Expenditures
-604.61-419.07-470.08-440.76-294.36-115.41
Upgrade
Sale of Property, Plant & Equipment
-0.610.150.110.540.120.31
Upgrade
Cash Acquisitions
----13.87--25.58
Upgrade
Investment in Securities
-1,909-757.4736.06610.72-887.57-24.94
Upgrade
Other Investing Activities
-1.6614.3433.4213.519.0311.99
Upgrade
Investing Cash Flow
-2,516-1,162-400.5170.14-1,173-153.62
Upgrade
Short-Term Debt Issued
----3,0732,059
Upgrade
Long-Term Debt Issued
-3,3993,3582,1261,266-
Upgrade
Total Debt Issued
4,0013,3993,3582,1264,3392,059
Upgrade
Short-Term Debt Repaid
-----2,311-1,011
Upgrade
Long-Term Debt Repaid
--3,094-3,441-2,687--
Upgrade
Total Debt Repaid
-2,687-3,094-3,441-2,687-2,311-1,011
Upgrade
Net Debt Issued (Repaid)
1,314305.39-83.41-560.942,0281,048
Upgrade
Issuance of Common Stock
--0.3741.17227.355.99
Upgrade
Repurchase of Common Stock
-5.72-5.72-1.13-0.87-1.04-2.39
Upgrade
Common Dividends Paid
-235.29-248.47-226.65-191.75-261.21-100.64
Upgrade
Other Financing Activities
-6.87---200-19.57-
Upgrade
Financing Cash Flow
1,06651.2-310.81-912.391,973951.38
Upgrade
Foreign Exchange Rate Adjustments
65.3683.18-16.1120.05-9.884.41
Upgrade
Net Cash Flow
210.74591.51-131.97-38.57224.78-39.21
Upgrade
Free Cash Flow
990.641,200125.37242.87-860.21-956.79
Upgrade
Free Cash Flow Growth
126.47%857.27%-48.38%---
Upgrade
Free Cash Flow Margin
26.27%30.53%3.38%6.59%-29.51%-38.74%
Upgrade
Free Cash Flow Per Share
0.620.760.080.15-0.54-0.61
Upgrade
Cash Income Tax Paid
179.91108.8691.0146.06-5.82-134.78
Upgrade
Levered Free Cash Flow
1,0831,068-540.91-186.72-1,220-1,079
Upgrade
Unlevered Free Cash Flow
1,1341,119-504.75-129.08-1,184-1,065
Upgrade
Change in Net Working Capital
-1,831-1,549841.2560.571,5631,417
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.